![Ilan Vaknin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ilan Vaknin currently works at Chemomab Therapeutics Ltd., as Vice President-Research & Development from 2022.
Dr. Vaknin also formerly worked at Compugen Ltd., as Principal and Active P Ltd., as Chief Technology Officer.
Dr. Vaknin received his undergraduate degree, Masters Business Admin degree, and doctorate degree from The Hebrew University of Jerusalem.
| Companies | Position | Start |
|---|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Chief Tech/Sci/R&D Officer | 2022-08-11 |
| Companies | Position | End |
|---|---|---|
Active P Ltd.
 Active P Ltd. Pharmaceuticals: MajorHealth Technology Develops proprietary novel oral available peptide drugs to treat diabetes | Chief Tech/Sci/R&D Officer | - |
| COMPUGEN LTD. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
Compugen Ltd.
 Compugen Ltd. BiotechnologyHealth Technology Discovers and researches drug & diagnostics | Health Technology |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Active P Ltd.
Active P Ltd. Pharmaceuticals: MajorHealth Technology Develops proprietary novel oral available peptide drugs to treat diabetes | Health Technology |
Chemomab Therapeutics Ltd.
 Chemomab Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotech company | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
